Literature DB >> 5841048

Hemolysin titration based on fixation of the activated first component of complement: evidence that one molecule of hemolysin suffices to sensitize an erythrocyte.

T Borsos, H J Rapp.   

Abstract

Mesh:

Substances:

Year:  1965        PMID: 5841048

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  52 in total

1.  Activation of complement by immunoglobulin M is impaired by the substitution serine-406----asparagine in the immunoglobulin mu heavy chain.

Authors:  M J Shulman; N Pennell; C Collins; N Hozumi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

2.  Effect of rheumatoid factor and anti-immunoglobulin G antibodies on complement-mediated lysis of herpes simplex virus-infected human fibroblasts.

Authors:  J C Shivers; C A Daniels
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

3.  Immunoglobulin metabolism in ataxia telangiectasia.

Authors:  W Strober; R D Wochner; M H Barlow; D E McFarlin; T A Waldmann
Journal:  J Clin Invest       Date:  1968-08       Impact factor: 14.808

4.  Antibody-independent and -dependent opsonization of group B Streptococcus requires the first component of complement C1.

Authors:  N J Levy; D L Kasper
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

5.  The role of complement in the clearance of cold agglutinin-sensitized erythrocytes in man.

Authors:  C J Jaffe; J P Atkinson; M M Frank
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

6.  Fixation of the first component of complement (C'la) by human antibodies.

Authors:  W F Rosse
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

7.  Antibody-independent binding of the first component of complement (C1) and its subcomponent C1q to the S and R forms of Salmonella minnesota.

Authors:  F Clas; M Loos
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

8.  Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies.

Authors:  C L Koski; M E Sanders; P T Swoveland; T J Lawley; M L Shin; M M Frank; K A Joiner
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

9.  Membrane-controlled depletion of complement activity by spin-label-specific IgM.

Authors:  G M Humphries; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

10.  Interactions between mycoplasma pneumoniae and the first components of complement.

Authors:  W Bredt; B Wellek; H Brunner; M Loos
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.